Case Report
Published on 18 Mar 2025
Anlotinib for the treatment of recurrent and refractory hemangioblastomas: a case report and review of literature
in Neuro-Oncology and Neurosurgical Oncology
- 260 views
Case Report
Published on 18 Mar 2025
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Published on 18 Mar 2025
in Neuro-Oncology and Neurosurgical Oncology
Case Report
Published on 18 Mar 2025
in Neuro-Oncology and Neurosurgical Oncology
Case Report
Published on 17 Mar 2025
in Neuro-Oncology and Neurosurgical Oncology
Mini Review
Published on 13 Mar 2025
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Accepted on 07 Mar 2025
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Published on 07 Mar 2025
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Accepted on 06 Mar 2025
in Neuro-Oncology and Neurosurgical Oncology
Hypothesis and Theory
Accepted on 03 Mar 2025
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Published on 28 Feb 2025
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Published on 28 Feb 2025
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Published on 26 Feb 2025
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Published on 20 Feb 2025
in Neuro-Oncology and Neurosurgical Oncology
Case Report
Published on 20 Feb 2025
in Neuro-Oncology and Neurosurgical Oncology
Case Report
Published on 11 Feb 2025
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Published on 11 Feb 2025
in Neuro-Oncology and Neurosurgical Oncology